Corpus Intelligence IC Memo — CAMDEN-CLARK MEMORIAL HOSPITAL 2026-04-26 03:51 UTC
IC Memo — CAMDEN-CLARK MEMORIAL HOSPITAL
Investment Committee Memorandum | WV | 256 beds | Grade B | EBITDA uplift $26.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CAMDEN-CLARK MEMORIAL HOSPITAL

CCN 510058 | WOOD, WV | 256 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

CAMDEN-CLARK MEMORIAL HOSPITAL is a 256-bed suburban community hospital in WOOD, WV with $357.5M in net patient revenue and a -8.0% operating margin. The hospital serves a payer mix of 34.0% Medicare, 5.2% Medicaid, and 60.8% commercial.

Thesis: Undervalued. Our ML models identify $26.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.0% to -0.6% (+736bps).

Net Revenue HCRIS$357.5M
Current EBITDA COMPUTED$-28.5M
Operating Margin COMPUTED-8.0%
Occupancy HCRIS63.2%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS29.8%
Distress Probability ML45.8%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
10
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -8.0% places it below the state median. Among 10 size-comparable peers (128-512 beds), the median margin is -4.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (128-512), prioritizing same-state peers. 10 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CAMDEN-CLARK MEMORIAL HOSPITAL (Target)WV256$357.5M-8.0%
CABELL HUNTINGTON HOSPITALWV330$718.8M-1.8%
UNITED HOSPITAL CENTERWV232$516.4M9.4%
ST. MARYS MEDICAL CENTER INC.WV350$507.8M-9.8%
WHEELING HOSPITALWV189$411.4M-8.5%
CITY HOSPITAL INC.WV163$304.2M-2.8%
THOMAS MEMORIAL HOSPITALWV176$209.0M26.7%
RALEIGH GENERAL HOSPITALWV300$181.8M-6.5%
MONONGALIA GENERAL HOSPITALWV160$155.1M-5.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $26.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.5M+210bp18mo
Cost to Collect4.5%2.5%$7.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.3M+122bp9mo
Clean Claim Rate88.0%96.0%$229K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.5M
Cost to Collect
$7.1M
Denial Rate Reduction
$7.1M
A/R Days Reduction
$4.3M
Clean Claim Rate
$229K
Total EBITDA Uplift$26.3M
Current EBITDA$-28.5M
+ RCM Uplift+$26.3M
Pro Forma EBITDA$-2.2M
Current Margin-8.0%
Pro Forma Margin-0.6%
WC Released (1x)$13.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-43.8M$75.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-43.8M$68.7M0.00x-100.0%
Bull Case9.0x11.0x$-39.4M$141.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-39.4M$142.5M0.00x-100.0%
Bear Case11.0x10.0x$-48.2M$-42.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-48.2M$-61.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 10 hospitals with 128-512 beds
  • Same-state prioritization (n=11)
  • Comp margins: P25=-8.0% / P50=-4.0% / P75=2.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.